ArticleScientific reports2026
Enhancing Fusarium resistance in Nigella sativa via spray-induced gene silencing (SIGS) using chitosan nanoparticles with molecular and phytochemical perspectives.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fusarium oxysporum is the causal agent of vascular wilt disease, which makes it hard to grow and use Nigella sativa as medicine. This disease significantly reduces both yield and phytochemical quality. Traditional methods of control frequently utilize chemical fungicides; however, these can leave behind harmful residues and modify the bioactive profile of the crop. In this study, double-stranded RNA (dsRNA) targeting key pathogenicity genes (CYP51 and SGE1) of Fusarium oxysporum was designed and synthesized. This technique is known as Spray-Induced Gene Silencing (SIGS). We employed ionic gelation to mix the dsRNA with chitosan nanoparticles (CSNPs) to make it more stable, easier for leaves to take in, and able to release over time. Plants were sprayed with CSNP-dsRNA mixes at particular times during their growth, and a range of disease and quality measurements were systematically evaluated. Plants that had been treated with CSNP-dsRNA exhibited 68.4% reduced disease severity than plants that had just been exposed to the pathogen, with statistically significant effects (p ≤ 0.05). The severity of the disease was scored on a scale of 0-5. Quantitative PCR demonstrated that the treated plants had 70% reduced fungal biomass. This was associated with a 3.2- to 4.7-fold increase in the expression of defense-related genes (PR1, PDF1.2, and WRKY70) within 72 h of treatment. Biochemical analysis using HPLC demonstrated that the thymoquinone level in seeds from treated plants remained at approximately 94% of that in healthy controls. A 41.3% reduction seen in thymoquinone content in the seeds due to failure to treat the infection suggests that applications of SIGS followed by nanoparticle technology could have potential applications to either reduce the incidence of disease, stimulate healthy molecular defence mechanisms or protect the medicinal value of N. sativa. Moreover, SIGS is a viable, eco-friendly and harmless alternative to chemical fungicides, and could be applied to the management of profitable commercially planted crops that deliver considerable human health benefits; thus, providing a new and sustainable method to control plant disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.